About Changchun High-Tech Industries Company

The company was founded exclusively by Changchun High-tech Industry Development Corporation, with a total share capital of 137.5 million shares. In the more than 20 years since the company was listed, Changchun Hi-Tech has successfully transformed from the beginning of the company's establishment to focus on infrastructure construction in the high-tech zone to become an enterprise group focusing on the field of pharmaceutical science and technology innovation and implementing industrial investment. The company's main business is R&D, production and sales of biopharmaceuticals and proprietary Chinese medicines, as well as real estate development, property management and services. The main products are injectable human growth hormone (powder injection), recombinant human growth hormone injection (water injection), polyethylene glycol recombinant human growth hormone injection (long-acting water injection), follicle-stimulating hormone for injection, triproterin acetate injection, cetrorex acetate, topical human granulocyte macrophage stimulating factor gel, etc., covering all stages of the life cycle. The company received the most respected listed company for investment in 2017, certification as an academician and expert workstation, honors such as famous brand products in Jilin Province in 2012, and the top 100 enterprises in the pharmaceutical manufacturing industry in China.